Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks Electric Regulatory News (MRK)

Share Price Information for Marks Electric (MRK)

Share Price is delayed by 15 minutes
Get Live Data
45.50    0.00 (0.00%)
Bid:
45.00
Ask:
46.00
Spread: 1.00 (2.222%)
Market Cap: £47.33m
MRK Live PriceLast checked at - London Stock Exchange

Intraday Marks Electric Share Chart

Related Party Transaction

1 Apr 2022 07:00

RNS Number : 8670G
Marks Electrical Group plc
01 April 2022
 

1 April 2022

Marks Electrical Group plc

("Marks Electrical" or "Company")

Related Party Transaction

The Company confirms that as part of the completion of its financial full year, its wholly owned subsidiary, Marks Electrical Limited ("MEL") settled a net cash payment of £628,510 on 31 March 2022, to Mark Smithson (CEO) in relation to previously disclosed historical arrangements. The payment is subject to PAYE and NIC taxes resulting in a total outflow of £1.35m.

This process is part of a year-end settlement and brings to a close the aforementioned historical arrangements as outlined in the Company's Admission Document at the time of its IPO. There is no financial impact on the Company or its current trading given that these balances were already provided for on the Balance Sheet. Further details of this arrangement are described in the Admission Document, dated 5 November 2021.

Following this net cash payment, the Company has a closing cash balance on 31 March 2022 of over £3.0m.

The Group looks forward to providing an update on the progress it has made during the financial year ended 31 March 2022 with the release of its pre-close full year trading update on 12 April 2022.

Related party transactions

Given Mark Smithson's position as a Director and substantial shareholder of the Company, the settlement to Mark Smithson is deemed to be a related party transaction pursuant to AIM Rule 13 of the AIM Rule for Companies

Under the AIM Rules, where a company enters into a related party transaction, the independent directors of that company are required, after consulting with the company's nominated adviser, to state whether, in their opinion, the transaction is fair and reasonable in so far as its shareholders are concerned.

The Independent Directors, being Marnie Millard, David Wilkinson and Aly Fadil, have considered the terms of the settlement and having consulted with Panmure Gordon, the Company's nominated adviser, the Independent Directors of the Company believe that the terms of the settlement are fair and reasonable in so far as the Company's shareholders are concerned.

 

Enquiries:

Marks Electrical Group plc

Via Dentons Global Advisors:

Tel: +44 (0) 7510 385 554

 

Mark Smithson, CEO

 

 

Josh Egan, CFO

 

Dentons Global Advisors (Financial PR)

markselectrical@dentonsglobaladvisors.com

Tel: +44 (0) 7510 385 554

James Styles

Fern Duncan

Panmure Gordan (NOMAD and Broker)

+44 (0) 207 886 2500

Oliver Cardigan, Ailsa Macmaster (Corporate Finance)

Erik Anderson (Corporate Broking)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFLLXLXLFBBQ
12
Date   Source Headline
19th Jun 20267:00 amRNSFY26 Financial Results
18th Jun 202610:25 amRNSConclusion of CMA Investigation
13th Apr 20267:00 amRNSTrading Update and Update on Outlook
26th Mar 20267:00 amRNSPre Close Trading Update & Board Change
18th Feb 20264:16 pmRNSHolding(s) in Company
17th Feb 20262:43 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSBoard Change
23rd Jan 20267:00 amRNSBoard Change
2nd Jan 20267:00 amRNSDirector Appointment
2nd Jan 20267:00 amRNSDirector Appointment
4th Dec 20257:00 amRNSChair Succession
20th Nov 202512:42 pmRNSHolding(s) in Company
19th Nov 20254:48 pmRNSHolding(s) in Company
18th Nov 202510:54 amRNSResponse to CMA Announcement
13th Nov 20257:00 amRNSHY26 Interim Results
26th Sep 20256:19 pmRNSHolding(s) in Company
25th Sep 20257:00 amRNSQ2 Trading Update
7th Aug 20254:05 pmRNSResult of AGM
1st Aug 20257:00 amRNSCFO Update
2nd Jul 20257:00 amRNSNotice of AGM and Dividend Declaration
25th Jun 20257:00 amRNSFY25 Results
6th Jun 20257:00 amRNSDirectorate Change
4th Jun 20257:00 amRNSHolding(s) in Company
10th Apr 20257:00 amRNSFY25 Pre-close Trading Statement
17th Mar 20252:27 pmRNSHolding(s) in Company
3rd Feb 20253:29 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSHolding(s) in Company
10th Jan 20254:49 pmRNSDirector/PDMR Shareholding
10th Jan 20257:00 amRNSHolding(s) in Company
27th Nov 20247:00 amRNSHolding(s) in Company
26th Nov 20247:00 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSHY25 Interim Results
1st Nov 20247:00 amRNSDirectorate Change
17th Oct 20247:00 amRNSDirectorate Change
8th Aug 20243:59 pmRNSResult of AGM
10th Jul 20247:00 amRNSDirector/PDMR Shareholding
8th Jul 20243:33 pmRNSNotice of AGM and Publication of Annual Report
26th Jun 20247:00 amRNSFinal Results
4th Jun 20244:46 pmRNSNotice of Results
25th Apr 20247:00 amRNSDirector/PDMR Shareholdings
18th Apr 202412:12 pmRNSLease Extension
16th Apr 20247:00 amRNSQ4-24 pre close trading update
6th Mar 20246:34 pmRNSAIM Notice Rule 17
5th Feb 202412:39 pmRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSDirector/PDMR Shareholding
10th Jan 202412:07 pmRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSTrading Update
23rd Nov 202310:43 amRNSHolding(s) in Company
16th Nov 20237:00 amRNSHY24 Interim Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.